Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series
Article in Frontiers in Immunology (July 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (July 2024)
Article in Nature Reviews Rheumatology (July 2024)
Article in CNS Drugs (May 2024)